v3.25.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2025
Segment Information [Abstract]  
Schedule of Revenue and Expense Categories of the Company’s Single Operating Segment The following table presents the significant revenue and expense categories of the Company’s single operating segment.
   For the three months ended March 31, 
   2025   2024 
   (Unaudited)   (Unaudited) 
Operating expenses:        
Clinical trial related service fee   1,375,000    
-
 
Consulting fee   25,000    25,000 
Stock-based compensation   159,095    
-
 
Salary expense   129,711    120,486 
Professional fee   285,090    199,156 
Insurance expense   81,057    87,493 
Other general and administrative fee   49,345    37,395 
Loss before income tax   2,104,298    469,530 
           
Income tax expense   13    
-
 
Net loss  $2,104,311   $469,530